Newmark announced that Noxilizer, one of Maryland’s fastest-growing biotech firms, will be moving to 10,481 square feet of space at 1334 Ashton Road in Hanover, Maryland. After five years at the University of Maryland BioPark in Baltimore City, the firm needs a more efficient facility to accommodate its growing market presence.
The new office is located in Anne Arundel County near Arundel Mills Mall, with easy access to the I-95 corridor and nearby amenities. Just five miles from Baltimore-Washington International Airport, 13 miles from both Downtown Baltimore and Downtown Columbia and 30 miles from Washington, DC, the company will be conveniently positioned for both employees and customers.
“The new office allows us to retain all of the advantages of urban connectivity while affording us the space we need to meet the growth we’re experiencing,” said Lawrence Bruder, President & CEO of Noxilizer. “It is thrilling to see this move as an objective sign of how much we have grown as a company over the past five years.”
Noxilizer provides room temperature nitrogen dioxide (NO2) sterilization equipment and bio-decontamination equipment to pharmaceutical, biotech and medical device manufacturers. Its proprietary technology offers many benefits over traditional sterilization methods, including ultra-low temperature (10°-30°C), minimal pressure requirements, no cytotoxic residuals, and fast cycle times (2-4 hours, including aeration). First commercialized by Noxilizer in 2012, NO2 sterilization opens new avenues for innovation and has been shown to be particularly effective in the sterilization of prefilled syringes, drug-device combination products, and custom implants. The company’s customers include Fortune 150 pharmaceutical and medical device companies.
The Ashton Road property is owned by Feldman Bergin Development in partnership with Kenwood Management Company. The landlord was represented by Marley Welsh and Kate Jordan of Lee & Associates, while Michael Singer and Matthew Lunnen of Newmark represented the tenant.
Noxilizer, Inc. provides an ultra-low temperature nitrogen dioxide process that offers many benefits over traditional sterilization and biodecontamination methods. Noxilizer sells sterilization and biodecontamination equipment to pharmaceutical, biotech and medical device manufacturers. Noxilizer’s expert microbiology and material compatibility team is ready to partner to solve sterilization challenges through every phase of the process. Noxilizer, Inc. has offices in the United States and Japan. For more information, please visit: www.noxilizer.com.
Newmark is one of the world’s leading commercial real estate advisory firms. Together with London-based partner Knight Frank and independently-owned offices, Newmark’s 15,000 professionals operate from more than 400 offices in established and emerging property markets on six continents.
With roots dating back to 1929, Newmark’s strong foundation makes it one of the most trusted names in commercial real estate. Newmark’s full-service platform comprises BGC’s real estate services segment, offering commercial real estate tenants, landlords, investors and developers a wide range of services including leasing, corporate advisory services, consulting, project and development management, property and corporate facilities management services, valuation and advisory services, and capital markets services provided through its Newmark Capital Markets brand. For further information, visit www.ngkf.com.
Newmark is a part of BGC Partners, Inc., a leading global brokerage company servicing the financial and real estate markets. BGC’s common stock trades on the NASDAQ Global Select Market under the ticker symbol (NASDAQ: BGCP). BGC also has an outstanding bond issuance of Senior Notes due June 15, 2042, which trade on the New York Stock Exchange under the symbol (NYSE: BGCA). BGC Partners is led by Chairman and Chief Executive Officer Howard W. Lutnick. For more information, please visit www.bgcpartners.com.